There are 2789 resources available
1235P - Comparative study between two 17-gray fractions versus thirteen 39-gray fractions palliative thoracic radiotherapy in advanced non-small cell lung carcinoma
Presenter: Syeda Tasmia
Session: ePoster Display
1236P - Poziotinib in NSCLC harbouring EGFR or HER2 exon 20 insertion mutation
Presenter: Arsela Prelaj
Session: ePoster Display
1237P - Gut microbiome profile and clinical correlations in advanced EGFR-WT and EGFR-mutant non-small cell lung cancer
Presenter: Woraseth Saifon
Session: ePoster Display
1238P - AUTOMAN: A phase Ib/IIa study of osimertinib combined with anlotinib in EGFRm, treatment-naive advanced NSCLC patients
Presenter: Baohui Han
Session: ePoster Display
1240P - Targeting exon 18 EGFR alterations in non-small cell lung cancer: A patient-level analysis of published data
Presenter: Mehmet Goksu
Session: ePoster Display
1241P - Effects of different brain radiotherapy strategies based on lung-molGPA stratification on the prognosis of patients with brain metastases of EGFR-mutant lung adenocarcinoma
Presenter: Guangchuan Deng
Session: ePoster Display
1242P - Anlotinib with gefitinib as first-line therapy in advanced non-small cell lung cancer harboring EGFR mutations: A phase II study
Presenter: Yajun Ji
Session: ePoster Display
1243P - Cumulative incidence and metastatic patterns of relapsed vs de novo stage IV non-small cell lung cancer (NSCLC) characterized by histology and EGFR status
Presenter: Evan Strom
Session: ePoster Display
1244P - Real-world EGFR and T790M testing patterns in patients from Central Eastern Europe with advanced non-small cell lung cancer: Results from a large retrospective study (REFLECT)
Presenter: Mircea Dediu
Session: ePoster Display